Viridien
Short position disclosed on September 22, 2026.
8.39% of the capital sold short
9 disclosing funds
2,491 disclosures on record
Evolution of the disclosed total
0%2.5%5%7.5%10%
Oct 2025Jan 2026Apr 2026Jul 2026
January 7, 2013 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since | Filing |
|---|---|---|---|---|---|
| Capital Fund Management | 1.52% | +0.95 pt | September 15, 2026 | ||
| Marshall Wace LLP | 1.40% | -0.11 pt | September 22, 2026 | ||
| Citadel Advisors LLC | 1.12% | +0.34 pt | September 21, 2026 | ||
| Worldquant, LLC | 1.03% | new | September 22, 2026 | ||
| Walleye Capital LLC | 0.71% | new | August 17, 2026 | AMF | |
| TWO Sigma Investments, LP | 0.70% | new | August 19, 2026 | AMF | |
| Tudor Capital Europe LLP | 0.70% | new | September 21, 2026 | ||
| Acadian Asset Management LLC | 0.64% | new | September 22, 2026 | ||
| Mirabella Financial Services LLP | 0.57% | unchanged | January 30, 2025 | AMF |
In the United States CGPVF (OTC): 7,682 shares sold short on September 15, 2026. FINRA names no fund.
On the other side: the funds that hold Viridien Titelia
Get the moves on Viridien by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication | Filing |
|---|---|---|---|---|
| October 20, 2023 | POINT72 Asset Management, L.P. | 0.69% | November 9, 2023 | AMF |
| October 19, 2023 | ActusRayPartners Limited | 0.50% | November 16, 2023 | |
| October 18, 2023 | Qube Research & Technologies Limited | 1.75% | March 4, 2024 | |
| October 17, 2023 | Marshall Wace LLP | 1.22% | March 24, 2025 | |
| October 17, 2023 | ActusRayPartners Limited | 0.47% | October 19, 2023 | |
| October 16, 2023 | Qube Research & Technologies Limited | 1.88% | March 4, 2024 | |
| October 13, 2023 | Marshall Wace LLP | 1.13% | March 24, 2025 | |
| October 12, 2023 | Qube Research & Technologies Limited | 1.97% | March 4, 2024 | |
| October 12, 2023 | ActusRayPartners Limited | 0.51% | October 19, 2023 | |
| October 11, 2023 | POINT72 Asset Management, L.P. | 0.78% | November 9, 2023 | AMF |
| October 10, 2023 | Qube Research & Technologies Limited | 2.01% | March 4, 2024 | |
| October 6, 2023 | Marshall Wace LLP | 1.00% | March 24, 2025 | |
| October 5, 2023 | Marshall Wace LLP | 0.95% | March 24, 2025 | |
| October 3, 2023 | Qube Research & Technologies Limited | 1.90% | March 4, 2024 | |
| October 3, 2023 | POINT72 Asset Management, L.P. | 0.88% | November 9, 2023 | AMF |
| October 2, 2023 | Qube Research & Technologies Limited | 1.82% | March 4, 2024 | |
| October 2, 2023 | POINT72 Asset Management, L.P. | 0.90% | November 9, 2023 | AMF |
| September 28, 2023 | Qube Research & Technologies Limited | 1.76% | March 4, 2024 | |
| September 26, 2023 | Qube Research & Technologies Limited | 1.60% | March 4, 2024 | |
| September 26, 2023 | Marshall Wace LLP | 0.87% | March 24, 2025 | |
| September 25, 2023 | Marshall Wace LLP | 0.91% | March 24, 2025 | |
| September 22, 2023 | Qube Research & Technologies Limited | 1.53% | March 4, 2024 | |
| September 22, 2023 | POINT72 Asset Management, L.P. | 0.82% | November 9, 2023 | AMF |
| September 21, 2023 | Qube Research & Technologies Limited | 1.43% | March 4, 2024 | |
| September 19, 2023 | POINT72 Asset Management, L.P. | 0.70% | November 9, 2023 | AMF |
| September 18, 2023 | Qube Research & Technologies Limited | 1.09% | March 4, 2024 | |
| September 18, 2023 | Marshall Wace LLP | 0.82% | March 24, 2025 | |
| September 18, 2023 | Citadel Advisors LLC | 0.47% | September 20, 2023 | |
| September 15, 2023 | Qube Research & Technologies Limited | 1.28% | March 4, 2024 | |
| September 15, 2023 | Marshall Wace LLP | 0.71% | March 24, 2025 | |
| September 14, 2023 | Qube Research & Technologies Limited | 1.35% | March 4, 2024 | |
| September 13, 2023 | Qube Research & Technologies Limited | 1.43% | March 4, 2024 | |
| September 13, 2023 | POINT72 Asset Management, L.P. | 0.60% | November 9, 2023 | AMF |
| September 8, 2023 | Qube Research & Technologies Limited | 1.39% | March 4, 2024 | |
| September 6, 2023 | Marshall Wace LLP | 0.66% | March 24, 2025 | |
| September 6, 2023 | POINT72 Asset Management, L.P. | 0.52% | November 9, 2023 | AMF |
| September 5, 2023 | Qube Research & Technologies Limited | 1.49% | March 4, 2024 | |
| September 5, 2023 | Marshall Wace LLP | 0.70% | March 24, 2025 | |
| September 4, 2023 | Qube Research & Technologies Limited | 1.59% | March 4, 2024 | |
| September 1, 2023 | Qube Research & Technologies Limited | 1.60% | March 4, 2024 | |
| August 31, 2023 | Citadel Advisors LLC | 0.69% | September 20, 2023 | |
| August 30, 2023 | Qube Research & Technologies Limited | 1.73% | March 4, 2024 | |
| August 30, 2023 | Marshall Wace LLP | 0.62% | March 24, 2025 | |
| August 25, 2023 | Citadel Advisors LLC | 0.78% | September 20, 2023 | |
| August 24, 2023 | Citadel Advisors LLC | 0.80% | September 20, 2023 | |
| August 23, 2023 | Qube Research & Technologies Limited | 1.84% | March 4, 2024 | |
| August 22, 2023 | Qube Research & Technologies Limited | 1.78% | March 4, 2024 | |
| August 21, 2023 | Qube Research & Technologies Limited | 1.82% | March 4, 2024 | |
| August 17, 2023 | Citadel Advisors LLC | 0.79% | September 20, 2023 | |
| August 17, 2023 | Marshall Wace LLP | 0.53% | March 24, 2025 |
The AMF column opens the filing the fund itself lodged, on the regulator own site.
Download 2491 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in France
- Ubisoft Entertainment 12.35% of the capital sold short
- Valeo 11.29% of the capital sold short
- Renault 9.50% of the capital sold short
- Teleperformance 6.31% of the capital sold short
- FDJ United 6.19% of the capital sold short
- Alstom 4.57% of the capital sold short
- Elis 4.57% of the capital sold short
- Abivax 4.47% of the capital sold short
- Rémy Cointreau 4.46% of the capital sold short
- DBV Technologies 4.21% of the capital sold short
- VusionGroup 3.91% of the capital sold short
- Sopra Steria Group 3.90% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Viridien, source AMF, data as at September 22, 2026, https://www.quivad.com/action/viridien?page=12